Whey protein exosome trial for ulcerative colitis
Part of Digestive system clinical trials.
This trial tests whether exosomes from milk can help adults with ulcerative colitis. Exosomes are tiny particles that may reduce inflammation in the colon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of ulcerative colitis (UC).
- You must be between 18 and 65 years old.
- You must have had a colonoscopy showing active inflammation.
- You cannot be pregnant or breastfeeding.
- You cannot have a milk allergy.
- You cannot have serious health problems like uncontrolled diabetes, heart or lung disease, cancer, HIV, hepatitis B or C, or abnormal liver tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether an oral treatment called MS-20 can improve ulcerative colitis (UC) in adults with moderate to severe disease. You may be asked to provide stool samples from home and avoid certain foods and medicines before screening and during the study.
This trial tests if low-intensity ultrasound waves applied to the colon can reduce inflammation in people with active ulcerative colitis. If successful, it could offer a new drug-free way to manage flare-ups.
This trial tests whether a prebiotic supplement can improve symptoms of ulcerative colitis. It may be a good option for people with active symptoms who are already on stable medications.
This study tests whether a special diet designed to improve your gut bacteria can help control mild ulcerative colitis. You'll receive prepared meals and follow the diet for several weeks to see if it reduces inflammation in your colon.
This study tests a new medication called BI 3032950 for people with ulcerative colitis who have already tried other advanced treatments (biologics or targeted therapies) that didn't work well enough or caused problems. The goal is to see if the new drug is safe and helps control inflammation in the colon.
This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.